drugset / Trial / NCT01357317

Study Comparing Effects of Lanthanum Carbonate Versus Calcium Acetate Versus Dietary Phosphorus Restriction

NCT01357317

RandomizedParallel-groupOpen-labelTreatment

Summary

Objective: To examine the effects of three commonly applied treatments of disordered phosphorus homeostasis on biochemical markers and vascular characteristics in patients with moderate and advanced non-dialysis dependent chronic kidney disease.

Timeline

Start
2011-06
Primary completion
2013-10
Completion
2014-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Calcium carbonate Other / unclassified 667 mg
Comparator Lanthanum Carbonate Other / unclassified 500 mg